Ibi-334 (Anti-B7-H3 & EGFR)
Ibi-334 is an ADCC-enhanced bispecific antibody targeting B7-H3 and EGFR, showing potent preclinical efficacy in solid tumors. It blocks EGFR signaling while utilizing a finely tuned B7-H3 arm to enhance inhibition. M.W 145.58 kDa.
| Catalog Number | A4042 |
| CAS# | N/A |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/ibi-334.html |